Advanced Accelerator Applications - AAA

Advanced Accelerator Applications



AAA
Home > Company > About Us

About Us

Advanced Accelerator Applications (AAA), is a European Pharmaceutical Group founded in 2002 by Italian academics as a spin-off of the “European Organization for Nuclear Research” (CERN), Geneva, Switzerland), to develop innovative diagnostic and therapeutic applications and products. AAA main focus is on products addressing Molecular Imaging and Therapy for the personalized treatment of serious diseases (the so-called Personalized Medicine).

AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology.

With 10 production facilities and R&D laboratories and more than 130 employees in 4 countries (France, Italy, Switzerland and Spain), AAA is a truly “private public company” with over 75 private and institutional shareholders.


AAA